These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Islet B cell neoproliferation in early low dose streptozocin induced diabetes in mice: a ducto-endocrine proliferation?
    Author: Papaccio G, Esposito V, Mezzogiorno V.
    Journal: Acta Morphol Hung; 1991; 39(1):43-52. PubMed ID: 1836928.
    Abstract:
    Several authors have documented cases of newly forming B cells from ductules of diabetic animals in their studies but few have enlarged on this phenomenon. We, therefore, diabetized 15 mice, with low dose injections of streptozocin (STZ) for 5 days, and observed their pancreatic islets 6 (group 1) and 14 (group 2) days after the last STZ injection in order to further the argument. We found that: i) mice without infiltration of their islets did not present any newly formed B cells; ii) mice belonging to group one, showing a mild or scarce lymphomonocytic infiltration, had a few (one or two) newly formed B cells; iii) mice belonging to group two, showing a massive islet infiltration, had two to three neoformed B cells; iv) we observed in one animal intact newly formed islets of Langerhans with a clearly observable ductule within each of them, as in a case of nesidioblastosis. All these neoformations occurred in animals with very low insulin levels. Morphometric evaluations did not show any significant modification in the number of D cells in group one animals when compared to control D cell numbers, but showed an increase in group two animals. We believe that the formation of these newly formed B cells, that might be named "ducto-endocrine proliferation", is an attempt to compensate for the loss of B cells at the onset of the diabetic syndrome.
    [Abstract] [Full Text] [Related] [New Search]